Pages that link to "Q33880730"

The following pages link to Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection (Q33880730):

Displaying 22 items.

• Recent progress in West Nile virus diagnosis and vaccination (Q21284433) (← links)
• Vaccines in development against West Nile virus (Q26999702) (← links)
• Experimental infection of rhesus macaques and common marmosets with a European strain of West Nile virus (Q27304916) (← links)
• A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations (Q27321020) (← links)
• Vaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus (Q27329490) (← links)
• Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond (Q29994527) (← links)
• Current trends in West Nile virus vaccine development (Q34788758) (← links)
• Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling. (Q35742553) (← links)
• Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis (Q36411126) (← links)
• TLR3- and MyD88-dependent signaling differentially influences the development of West Nile virus-specific B cell responses in mice following immunization with RepliVAX WN, a single-cycle flavivirus vaccine candidate (Q37254256) (← links)
• Vaccines and Immunotherapeutics for the Prevention and Treatment of Infections with West Nile Virus (Q37842337) (← links)
• West Nile virus: the complex biology of an emerging pathogen (Q37876095) (← links)
• West Nile virus infection and immunity (Q38074266) (← links)
• Technologies for the development of West Nile virus vaccines (Q38269151) (← links)
• Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges (Q38269845) (← links)
• An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection (Q38866173) (← links)
• Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice (Q40222732) (← links)
• Immunogenicity of RepliVAX WN, a novel single-cycle West Nile virus vaccine (Q41218531) (← links)
• Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene (Q43039120) (← links)
• A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen (Q57299898) (← links)
• Nonhuman primate models of human viral infections (Q59350268) (← links)
• An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults (Q91129614) (← links)